Abstract:PURPOSE:Colon cancer ranks as the fourth common type of cancer and is responsible for significant morbidity and mortality throughout the world. Late diagnosis and the rarity of potent and safer chemotherapeutic drugs and efficient therapeutic targets create severe obstacle in the treatment of colon cancer. This study was undertaken to examine the anticancer effects of Evodiamine against human colon cancer cells.METHODS:The proliferation rate of the SW480 colon cancer cells was monitored by MTT assay. Apoptosis was detected by Annexin V/propidium iodide (PI) and acridine orange (AO)/ethidium bromide (EB) staining. Transmission electron microscopy (TEM) was used for detection of autophagy. Cell migration and invasion was detected by wound healing and transwell assays, respectively. Protein expression was determined by western blotting.RESULTS:Evodiamine suppressed the proliferation of the SW480 colon cancer cells and exhibited an IC50 of 10 µM. The cytotoxic effects of Evodiamine were found to be comparatively lower against the normal CDD-18Co colon cells as evidenced from the IC50 of 100 µM. AO/EB staining showed that Evodiamine caused apoptosis of the SW480 cells and the percentage of the apoptotic SW480 cells increased with increase in the Evodiamine concentration as indicated by annexin V/PI staining. Evodiamine-induced apoptosis was also accompanied by upregulation of caspase-3 and Bax and suppression of Bcl-2. TEM analysis showed that Evodiamine also activated autophagy in the SW480 cells by enhancing the expression of LC3 II and Beclin 1. The wound assay showed that Evodiamine suppressed the migration of the SW480 cells. Evodiamine also reduced the invasion potential of the SW480 cells as suggested by the transwell assay.CONCLUSION:The findings of the present study suggest that Evodiamine is a potent anticancer agent and may prove beneficial in the development of systemic therapy of colon cancer.

Studied on the antitumor activities of alkaloid from Evodia rutaecarpa

Evodiamine Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cells.

Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia Rutaecarpa

Antitumor Activity and Theoretical Calculation of Evodiamine and Rutaecarpine

Evodiamine, A Novel Inhibitor Of The Wnt Pathway, Inhibits The Self-Renewal Of Gastric Cancer Stem Cells

Antianoxic action of evodiamine, an alkaloid in Evodia rutaecarpa fruit

Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis

Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa

Studies on the Chemical Constituents of Evodia Rutaecarpa and Evodia Rutaecarpa Passed with Liquorice and Biological Activities

Research on Anti-Tumor Activity of Evodiamine in Vitro

Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti-cancer activity and bioavailability (Review)

Intestinal anti-inflammatory effects of main components of the fruits of Euodia rutaecarpa in a co-culture model of the human colorectal adenocarcinoma cells and RAW264.7 macrophages

Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives

Design, Synthesis and Bioactivity Evaluation of Novel N-phenyl-substituted Evodiamine Derivatives As Potent Anti-Tumor Agents

Advances in the Research of Biological Activities of Evodiamine Derivatives

New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives As Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations.

Recent advances in the antitumor effects of evodiamine

Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease

Synthesis , in vitro and in vivo antitumor activity and docking studies of new evodiamine derivatives

Evodiamine Exerts Anticancer Effects Via Induction of Apoptosis and Autophagy and Suppresses the Migration and Invasion of Human Colon Cancer Cells.

Alkaloids from the nearly ripe fruits of Evodia rutaecarpa and their bioactivities